Phase 3 Study of AK156 in Primary Osteoporosis Patients
Phase of Trial: Phase III
Latest Information Update: 01 Jan 2018
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Osteoporosis; Vertebral fracture
- Focus Therapeutic Use
- Acronyms ZONE
- Sponsors Asahi Kasei
- 01 Oct 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 06 Feb 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 03 Feb 2012 New trial record